Nufactor Revenue and Competitors
Estimated Revenue & Valuation
- Nufactor's estimated annual revenue is currently $31M per year.
- Nufactor's estimated revenue per employee is $201,000
Employee Data
- Nufactor has 154 Employees.
- Nufactor grew their employee count by 5% last year.
Nufactor's People
Name | Title | Email/Phone |
---|---|---|
1 | EVP, Sales | Reveal Email/Phone |
2 | Regional VP Sales | Reveal Email/Phone |
3 | Director Pharmacy | Reveal Email/Phone |
4 | Director Pharmacy | Reveal Email/Phone |
5 | Chief Operations Officer | Reveal Email/Phone |
6 | Director Admissions & Authorizations | Reveal Email/Phone |
7 | National Director Customer Service | Reveal Email/Phone |
8 | Director Account Development | Reveal Email/Phone |
9 | Director Admissions & Authorizations | Reveal Email/Phone |
10 | Account Manager | Reveal Email/Phone |
Nufactor Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.7M | 123 | 13% | N/A | N/A |
What Is Nufactor?
Since 1995, NuFACTOR has been providing the specialty products and care that infusion patients deserve, to help solve the acute problems of availability, affordability and safety in chronic care. Our corporate headquarters in Temecula, California, is shared with our parent company, FFF Enterprises, the nation's largest and most trusted distributor of specialty biopharmaceuticals. With FFF, NuFACTOR has the distinction of carrying all FDA-approved immune globulin products. In addition, NuFACTOR's portfolio includes all antihemophilic factors approved for use in the United States. Refer a patient today, visit: http://www.nufactor.com/ReferralFormsProviders.aspx Referral Fax: (855) 270-7347
keywords:N/AN/A
Total Funding
154
Number of Employees
$31M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $47.2M | 169 | 5% | N/A |
#2 | $45.5M | 188 | 4% | N/A |
#3 | $52.2M | 189 | 66% | N/A |
#4 | $64.1M | 232 | 8% | N/A |
#5 | $53.8M | 233 | 4% | N/A |